Canada markets open in 26 minutes

Dr. Reddy's Laboratories Limited (RDY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
74.78+0.80 (+1.08%)
At close: 04:00PM EDT
74.78 0.00 (0.00%)
After hours: 04:04PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 12.56B
Enterprise Value 11.93B
Trailing P/E 19.93
Forward P/E 20.45
PEG Ratio (5 yr expected) 4.94
Price/Sales (ttm)3.83
Price/Book (mrq)3.88
Enterprise Value/Revenue 0.04
Enterprise Value/EBITDA 0.14

Trading Information

Stock Price History

Beta (5Y Monthly) 0.34
52-Week Change 323.03%
S&P500 52-Week Change 322.43%
52 Week High 377.72
52 Week Low 353.12
50-Day Moving Average 374.08
200-Day Moving Average 369.92

Share Statistics

Avg Vol (3 month) 3190.21k
Avg Vol (10 day) 3203.23k
Shares Outstanding 5166.53M
Implied Shares Outstanding 6167.89M
Float 8119.82M
% Held by Insiders 10.00%
% Held by Institutions 115.17%
Shares Short (Apr 15, 2024) 4751k
Short Ratio (Apr 15, 2024) 43.51
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.45%
Shares Short (prior month Mar 15, 2024) 4709.29k

Dividends & Splits

Forward Annual Dividend Rate 40.49
Forward Annual Dividend Yield 40.65%
Trailing Annual Dividend Rate 340.00
Trailing Annual Dividend Yield 354.07%
5 Year Average Dividend Yield 40.72
Payout Ratio 412.78%
Dividend Date 3Aug 11, 2023
Ex-Dividend Date 4Jul 07, 2023
Last Split Factor 22:1
Last Split Date 3Sept 07, 2006

Financial Highlights

Currency in INR.

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 19.24%
Operating Margin (ttm)24.74%

Management Effectiveness

Return on Assets (ttm)12.38%
Return on Equity (ttm)21.39%

Income Statement

Revenue (ttm)271.3B
Revenue Per Share (ttm)272.46
Quarterly Revenue Growth (yoy)6.60%
Gross Profit (ttm)N/A
EBITDA 80.98B
Net Income Avi to Common (ttm)52.21B
Diluted EPS (ttm)3.75
Quarterly Earnings Growth (yoy)10.60%

Balance Sheet

Total Cash (mrq)72.55B
Total Cash Per Share (mrq)435.7
Total Debt (mrq)19.85B
Total Debt/Equity (mrq)7.41%
Current Ratio (mrq)2.55
Book Value Per Share (mrq)1,608.58

Cash Flow Statement

Operating Cash Flow (ttm)53.59B
Levered Free Cash Flow (ttm)23.21B